Clear Creek Financial Management LLC acquired a new position in Danaher Corporation (NYSE:DHR - Free Report) during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 1,277 shares of the conglomerate's stock, valued at approximately $262,000.
Other institutional investors have also recently made changes to their positions in the company. FAS Wealth Partners Inc. increased its holdings in Danaher by 20.6% in the 4th quarter. FAS Wealth Partners Inc. now owns 9,597 shares of the conglomerate's stock worth $2,203,000 after acquiring an additional 1,639 shares in the last quarter. Camden National Bank grew its holdings in Danaher by 285.0% during the 4th quarter. Camden National Bank now owns 7,227 shares of the conglomerate's stock valued at $1,659,000 after buying an additional 5,350 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in Danaher by 11.4% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 5,677,032 shares of the conglomerate's stock valued at $1,303,163,000 after buying an additional 579,046 shares in the last quarter. Terra Alpha Investments LLC purchased a new stake in Danaher during the 4th quarter valued at approximately $3,068,000. Finally, Rathbones Group PLC grew its holdings in Danaher by 2.5% during the 4th quarter. Rathbones Group PLC now owns 319,502 shares of the conglomerate's stock valued at $73,342,000 after buying an additional 7,695 shares in the last quarter. Institutional investors own 79.05% of the company's stock.
Insider Activity
In other Danaher news, Chairman Steven M. Rales sold 1,250,000 shares of Danaher stock in a transaction dated Monday, May 12th. The stock was sold at an average price of $196.74, for a total value of $245,925,000.00. Following the transaction, the chairman owned 3,105,808 shares in the company, valued at $611,036,665.92. The trade was a 28.70% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Christopher Paul Riley sold 15,805 shares of Danaher stock in a transaction dated Wednesday, April 30th. The shares were sold at an average price of $198.00, for a total value of $3,129,390.00. Following the completion of the transaction, the executive vice president owned 15,179 shares in the company, valued at $3,005,442. This trade represents a 51.01% decrease in their position. The disclosure for this sale can be found here. Insiders own 11.20% of the company's stock.
Danaher Trading Down 1.8%
Shares of NYSE:DHR traded down $3.60 on Monday, hitting $199.60. 2,388,352 shares of the company's stock were exchanged, compared to its average volume of 3,495,259. Danaher Corporation has a 12 month low of $171.00 and a 12 month high of $281.70. The stock has a market capitalization of $142.85 billion, a price-to-earnings ratio of 38.76, a price-to-earnings-growth ratio of 2.85 and a beta of 0.77. The business's 50 day simple moving average is $195.71 and its two-hundred day simple moving average is $206.90. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.43 and a quick ratio of 1.05.
Danaher (NYSE:DHR - Get Free Report) last released its quarterly earnings data on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share for the quarter, beating the consensus estimate of $1.62 by $0.26. The firm had revenue of $5.74 billion during the quarter, compared to the consensus estimate of $5.58 billion. Danaher had a return on equity of 10.80% and a net margin of 15.81%. Analysts anticipate that Danaher Corporation will post 7.63 EPS for the current fiscal year.
Danaher Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 25th. Investors of record on Friday, June 27th will be issued a $0.32 dividend. This represents a $1.28 annualized dividend and a dividend yield of 0.64%. Danaher's payout ratio is currently 24.85%.
Analyst Ratings Changes
A number of equities research analysts have issued reports on the stock. Bank of America cut their price objective on shares of Danaher from $265.00 to $230.00 in a report on Monday, April 14th. Royal Bank Of Canada reaffirmed an "outperform" rating and set a $250.00 price objective on shares of Danaher in a report on Wednesday, April 23rd. Argus cut their target price on shares of Danaher from $260.00 to $240.00 in a report on Wednesday, April 23rd. Citigroup reissued a "buy" rating on shares of Danaher in a report on Monday, April 7th. Finally, TD Cowen raised their target price on shares of Danaher from $240.00 to $248.00 and gave the company a "buy" rating in a report on Wednesday, April 23rd. Four analysts have rated the stock with a hold rating and seventeen have assigned a buy rating to the company's stock. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of $248.61.
Read Our Latest Report on DHR
Danaher Company Profile
(
Free Report)
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Read More

Before you consider Danaher, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.
While Danaher currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report